Disclaimer

The alfapump® system is not currently approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. For more information regarding the POSEIDON clinical study see www.poseidonstudy.com.
The DSR therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed.
The DSR therapy is not currently approved for clinical research in the United States or Canada. There is no link between the DSR therapy and ongoing investigations with the alfapump® system in Europe.

Events & Presentations

Upcoming Scientific Events
AASLD

13-17 November 2020, Boston, USA
website
 

Recent Scientific Presentations
GASL

14-15 February 2020, Mainz, Germany
website
 

Jahrestagung der Deutschen Gesellschaft für Thorax-, Herz- und Gefäßchirurgie

29 February-3 March 2020, Wiesbaden, Germany
website
 

DGVS

2-5 October 2019, Wiesbaden, Germany
Presentation by Prof. Wong during lunch symposium on 4 October 2019: “Refractory Ascites: Reduce Fluid – Increase Quality of Life”
download
website
 

TCT

25-30 September 2019, San Francisco, US
Presentation by Dr. Testani on 28 September 2019: Direct Sodium Removal with an ambulatory peritoneal dialysis system
download
website
 

HFA

25-28 May 2019, Athens, Greece
Presentation by Dr. Testani during late-breaking session on 27 May 2019 (for webcast go to Investor Relations Events & Presentations page)
download
website
 

EuroPCR

20-24 May 2019, Paris, France
Presentation by Ian Crosbie, CEO on 23 May 2019
download
website
 

The AASLD Liver Meeting

9-13 November 2018, San Francisco
Poster session on 10 November 2018 by Dr. Florence Wong
download
website
 

IGCS

14-16 September 2018, Kyoto, Japan
Poster session on 15 September by Prof. Dr. Christina Fotopoulou
download
website
 

HFSA 22nd Annual Scientific Meeting

15-18 September 2018, Tennessee
Poster session on 16 September by Dr. Jeffrey Testani
download
website

Investor Relations Events

For Investor Relations Events & Presentations, please visit our Investors page.

We would like to use cookies to better understand your use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our. Privacy & Cookie Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close